Submitted by Anonymous (not verified) on 16 October 2026 - 16:05
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 11, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Padcev, enfortumab vedotin, Date of authorisation: 13/04/2022, Revision: 11, Status: Authorised